In an industry built on research, Takeda Pharmaceutical Company relies heavily on internal development, and that requires extensive use of proprietary technologies, applications, and intellectual property. In the past, that dependence had slowed Takeda’s migration to the cloud. Looking to a cloud future, Takeda’s CISO envisioned “a model of remote access for applications that have historically been on-premise.”

And then the coronavirus outbreak hit. Like many multinational companies, Takeda saw its first operational impacts in China, where Towers notes branch offices were still using “legacy VPN infrastructure” on “dated network architectures that made application access and performance quite slow.” The solution? A “quick pivot to ZPA,” led by Towers and team.

Download the Takeda case study to know more.